Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;44(4):129-136.
doi: 10.18773/austprescr.2021.028. Epub 2021 Aug 2.

The ocular adverse effects of oral drugs

Rawan Ahmad  1 , Hemal Mehta  1   2
Affiliations
Review

The ocular adverse effects of oral drugs

Rawan Ahmad et al. Aust Prescr. 2021 Aug.

Erratum in

Abstract

Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a number of approaches, including monitoring for ocular toxicity, reducing the drug dose, or stopping the drug and looking for an alternative. This can be supported by good communication between the prescribing clinician and ophthalmologist Infrequent or delayed ocular adverse effects may not be identified in clinical trials of new drugs. Reporting adverse events is therefore important.

Keywords: eye; ocular toxicity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared

Figures

Fig
Fig
Examples of drugs affecting different parts of the eye
See this image and copyright information in PMC

References

    1. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications : recognition and management. Drugs 2007;67:75-93. 10.2165/00003495-200767010-00006 - DOI - PubMed
    1. Fung A, McCluskey P. Tamsulosin-induced intraoperative floppy iris syndrome during cataract surgery. Aust Prescr 2010;33:88-9. 10.18773/austprescr.2010.042 - DOI
    1. Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC. Amiodarone induced optic neuropathy. Br J Ophthalmol 2003;87:420-2. 10.1136/bjo.87.4.420 - DOI - PMC - PubMed
    1. Renard D, Rubli E, Voide N, Borruat FX, Rothuizen LE. Spectrum of digoxin-induced ocular toxicity: a case report and literature review. BMC Res Notes 2015;8:368. 10.1186/s13104-015-1367-6 - DOI - PMC - PubMed
    1. Luo C, Chen X, Jin H, Yao K. The association between gout and cataract risk: A meta-analysis. PLoS One 2017;12:e0180188. 10.1371/journal.pone.0180188 - DOI - PMC - PubMed

LinkOut - more resources